[Form 4] Viemed Healthcare, Inc. Insider Trading Activity

Insider Trade Summary

Exercise and Sale: 181,316 shares ($810K approx. pre-tax spread)

Exercise and Sale 10 txns

Insider Moore Michael

Role President

Sold 181,316 shs ($1.26M)

Approx. gross sale proceeds $1.26M

Approx. exercise cost $446K

Approx. pre-tax spread $810K

Type	Security	Shares	Price	Value
Exercise	Stock Options	127,053	$0.00	$0.00
Exercise	Stock Options	50,777	$0.00	$0.00
Exercise	Common Shares	127,053	$1.81	$230K
Sale	Common Shares	127,053	$6.92	$879K
Exercise	Common Shares	50,777	$4.13	$210K
Sale	Common Shares	50,777	$6.93	$352K
Exercise	Stock Options	3,486	$0.00	$0.00
Exercise	Common Shares	3,486	$1.81	$6K
Sale	Common Shares	3,486	$7.00	$24K
holding	Common Shares	--	--	--

Holdings After Transaction: Stock Options — 156,449 contracts (Direct); Common Shares — 177,433 shares (Direct); Common Shares — 1,722,614 shares (Indirect, by Moore Faster LLC)

Footnotes (2)

1. F1. Options granted to reporting person on January 4, 2018, which are fully vested.
2. F2. Options granted to reporting person on January 17, 2019, which are fully vested.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2025 - 04:08 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Moore Michael

(Last) (First) (Middle)

625 E. KALISTE SALOOM RD.

(Street)

LAFAYETTE LA 70508

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VIEMED HEALTHCARE, INC. [ VMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

3. Date of Earliest Transaction (Month/Day/Year)
06/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	06/27/2025		M		3,486	A	$1.81	180,919	D
Common Shares	06/27/2025		S		3,486	D	$7	177,433	D
Common Shares	06/30/2025		M		127,053	A	$1.81	304,486	D
Common Shares	06/30/2025		S		127,053	D	$6.92	177,433	D
Common Shares	06/30/2025		M		50,777	A	$4.13	228,210	D
Common Shares	06/30/2025		S		50,777	D	$6.93	177,433	D
Common Shares								1,722,614	I	by Moore Faster LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	$1.81	06/27/2025		M			3,486	(1)	01/04/2028	Common Shares	3,486	$0	127,053	D
Stock Options	$1.81	06/30/2025		M			127,053	(1)	01/04/2028	Common Shares	127,053	$0	0	D
Stock Options	$4.13	06/30/2025		M			50,777	(2)	01/17/2029	Common Shares	50,777	$0	156,449	D

Explanation of Responses:

1. Options granted to reporting person on January 4, 2018, which are fully vested.

2. Options granted to reporting person on January 17, 2019, which are fully vested.

Remarks:

	/s/ Jesse Bergeron, Attorney-in-Fact	07/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.